Pfizer Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Pfizer Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4423
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pfizer Inc. (Pfizer or ‘the company’) is a research based global biopharmaceutical company. The company provides medicines, vaccines, consumer healthcare products and therapies to treat various conditions including inflammation, cancer, besides vaccines, infection and immune disorders and rare diseases. It also provides active pharmaceutical ingredients (APIs), biosimilars, sterile injectable pharmaceuticals and contract manufacturing services. The company sells consumer healthcare products through pharmacies, distributors, retail chains and convenience stores. It also sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. The company offers its products in the US and international market. Pfizer is headquartered in New York, the US.

Scope

- Detailed information on Pfizer Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Pfizer Inc. including a breakdown and examination of key business segments
- Intelligence on Pfizer Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pfizer Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pfizer Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pfizer Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pfizer Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Pfizer Inc.: Company Overview 9
Pfizer Inc.: Overview and Key Facts 9
Pfizer Inc.: Overview 9
Pfizer Inc.: Key Facts 9
Pfizer Inc.: Key Employees 11
Pfizer Inc.: Key Employee Biographies 13
Pfizer Inc.: Major Products and Services 16
Pfizer Inc.: Company History 18
Pfizer Inc.: Management Statement 35
Pfizer Inc.: Locations and Subsidiaries 37
Pfizer Inc.: Key Competitors 38
Pfizer Inc.: Company Analysis 39
Pfizer Inc.: Business Description 39
Pfizer Inc.: SWOT Analysis 41
Pfizer Inc.: SWOT Overview 41
Pfizer Inc.: Strengths 41
Pfizer Inc.: Weaknesses 42
Pfizer Inc.: Opportunities 42
Pfizer Inc.: Threats 43
Pfizer Inc.: Corporate Financial Deals Activity 45
Pfizer Inc.: Financial Deals Overview 45
Pfizer Inc.: Targets and Partners 47
Pfizer Inc.: Top Deals 2014 – 2018YTD* 52
Pfizer Inc.: Advisors 53
Pfizer Inc.: Top Legal Advisors 53
Pfizer Inc.: Top Financial Advisors 53
Pfizer Inc.: Mergers and Acquisitions 55
Pfizer Inc.: Corporate Venturing 56
Pfizer Inc.: Capital Raising 57
Pfizer Inc.: Partnership 58
Pfizer Inc.: Divestments 59
Pfizer Inc.: Recent Developments 60
Pfizer Inc.: News and Events Summary 60
Pfizer Inc.: Business Expansion 63
Pfizer Inc.: Corporate Social Responsibility 64
Pfizer Inc.: Financial Deals 65
Pfizer Inc.: Financial Performance 66
Pfizer Inc.: Regulatory and Legal Events 66
Pfizer Inc.: Strategy and Operations 67
Appendix 69
Contact Us 69
Methodology 69
About MarketLine 70

List of Tables
Table 1: Pfizer Inc.: Key Facts
Table 2: Pfizer Inc.: Key Employees
Table 3: Pfizer Inc.: Locations and Subsidiaries
Table 4: Pfizer Inc.: Key Competitors
Table 5: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Pfizer Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Pfizer Inc.: Targets and Partners
Table 9: Pfizer Inc.: Top Deals 2014 - 2018YTD*
Table 10: Pfizer Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Pfizer Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Pfizer Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Pfizer Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Pfizer Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Pfizer Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Pfizer Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Pfizer Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Pfizer Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Pfizer Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: Pfizer Inc.: Divestments by Geography (2014 - YTD*2018)
Table 22: Pfizer Inc.: News and Events Summary
Table 23: Pfizer Inc.: Business Expansion
Table 24: Pfizer Inc.: Corporate Social Responsibility
Table 25: Pfizer Inc.: Financial Deals
Table 26: Pfizer Inc.: Financial Performance
Table 27: Pfizer Inc.: Regulatory and Legal Events
Table 28: Pfizer Inc.: Strategy and Operations

List of Figures
Figure 1: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Pfizer Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Pfizer Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Pfizer Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Pfizer Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Pfizer Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Pfizer Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Pfizer Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Pfizer Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 12: Pfizer Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 13: Pfizer Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Pfizer Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Israel Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Israel Institute of Technology (Technion) is a research university that offers science and technology programs. The university offers various undergraduate and graduate programs in biology, biomedical engineering, biotechnology and food engineering, chemical engineering, and medicine and env …
  • G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes disco …
  • CorMatrix Cardiovascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary CorMatrix Cardiovascular Inc (CorMatrix) is a medical device company that offers biomaterial devices. The company’s products comprise interim bioscaffolds, cardiovascular devices, biomaterials, cardiovascular medical devices, extracellular matrix materials, cardiovascular surgery devices, cr …
  • Cobb Electric Membership Corporation:発電所・企業SWOT分析
    Cobb Electric Membership Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • MiMedx Group Inc (MDXG):企業の製品パイプライン分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Therapix Biosciences Ltd (TRPX):企業の財務・戦略的SWOT分析
    Therapix Biosciences Ltd (TRPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • The Timken Company:企業の戦略・SWOT・財務分析
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Albert David Ltd (524075):企業の財務・戦略的SWOT分析
    Summary Albert David Ltd (ADL), a subsidiary of Kothari Group is a manufacturer and distributor of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles. The company’s products include sodium stibogluconate and placentrex. It offers pro …
  • Nan Ya Plastics Corporation:企業の戦略・SWOT・財務分析
    Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report Summary Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …
  • Sberbank Rossii:企業の戦略・SWOT・財務情報
    Sberbank Rossii - Strategy, SWOT and Corporate Finance Report Summary Sberbank Rossii - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析
    Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • JX Nippon Oil & Energy Corporation-エネルギー分野:企業M&A・提携分析
    Summary JX Nippon Oil & Energy Corporation (JXNOE) is a downstream refining company. The company refines and markets petroleum and petrochemical products. Its products include petrochemicals, lubricants, optical films, greases, fluids, engine oils, composites, Panaferd-AX, Tow PREPREG, sheet pallet …
  • Platte River Power Authority:発電所・企業SWOT分析
    Platte River Power Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • CooperSurgical Inc-医療機器分野:企業M&A・提携分析
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆